A Study of Anti-PD-1 AK105 in Patients With Metastatic Squamous Non-small Cell Lung Cancer

NCT03866993 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

350

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer Non-small Cell Stage IV
Squamous Cell Lung Cancer

Interventions

BIOLOGICAL: AK105
DRUG: Paclitaxel
DRUG: Carboplatin
DRUG: Placebo

Sponsor

Akeso

Collaborators

[object Object]